Simultaneously both expression of LMP-1 and methylation of E-cadherin: Molecular biomarker in stage IV of nasopharyngeal carcinoma patients

1Lao TD, Le TAH. MicroRNAs: Biogenesis, functions and potential biomarkers for early screening, prognosis and therapeutic molecular monitoring of nasopharyngeal carcinoma. Processes. 2020; 8(8): 966-1009.Lao TD Le TAH MicroRNAs: Biogenesis, functions and potential biomarkers for early screening, prognosis and therapeutic molecular monitoring of nasopharyngeal carcinoma Processes 2020 8 8 966 100910.3390/pr8080966Search in Google Scholar

2Tabuchi K, Nakayama M, Nishimura B, Hayashi K, Hara A. Early detection of nasopharyngeal carcinoma. Int J Otolaryngol. 2011; 2011: 638058.Tabuchi K Nakayama M Nishimura B Hayashi K Hara A Early detection of nasopharyngeal carcinoma Int J Otolaryngol 2011 2011 63805810.1155/2011/638058Search in Google Scholar

3Li M, Wang C, Yu B, Zhang X, Shi F, Liu X. Diagnostic value of RASSF1A methylation for breast cancer: A meta-analysis. Biosci Rep. 2019; 39(6): BSR20190923.Li M Wang C Yu B Zhang X Shi F Liu X Diagnostic value of RASSF1A methylation for breast cancer: A meta-analysis Biosci Rep 2019 39 6 BSR2019092310.1042/BSR20190923Search in Google Scholar

4Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol. 1992; 66(1): 122-131.Rowe M Lear AL Croom-Carter D Davies AH Rickinson AB Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes J Virol 1992 66 1 122 13110.1128/jvi.66.1.122-131.1992Search in Google Scholar

5Vera-Sempere FJ, Burgos JS, Botella MS, Cordoba J, Gobernado M. Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients. Eur J Cancer B Oral Oncol. 1996; 32B(3): 163-168.Vera-Sempere FJ Burgos JS Botella MS Cordoba J Gobernado M Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients Eur J Cancer B Oral Oncol 1996 32B 3 163–16810.1016/0964-1955(95)00093-3Search in Google Scholar

6Young LS, Dawson CW, Eliopoulos AG. The expression and function of Epstein-Barr virus encoded latent genes. Mol Pathol. 2000; 53(5): 238-247.Young LS Dawson CW Eliopoulos AG The expression and function of Epstein-Barr virus encoded latent genes Mol Pathol 2000 53 5 238 24710.1136/mp.53.5.238118697611091847Search in Google Scholar

7Lao TD, Nguyen DH, Nguyen TM, Le TAH. Molecular screening for Epstein-Barr virus (EBV): Detection of genomic EBNA-1, EBNA-2, LMP-1, LMP-2 among Vietnamese patients with nasopharyngeal brush samples. Asian Pac J Cancer Prev. 2017; 18(6): 1675-1679.Lao TD Nguyen DH Nguyen TM Le TAH Molecular screening for Epstein-Barr virus (EBV): Detection of genomic EBNA-1, EBNA-2, LMP-1, LMP-2 among Vietnamese patients with nasopharyngeal brush samples Asian Pac J Cancer Prev 2017 18 6 1675 1679Search in Google Scholar

8Lao TD, Nguyen TAH, Ngo KD, Thieu HH, Nguyen MT, Nguyen DH, et al. Molecular screening of nasopharyngeal carcinoma: Detection of LMP-1, LMP-2 gene expression in Vietnamese nasopharyngeal swab samples. Asian Pac J Cancer Prev. 2019; 20(9): 27572761.Lao TD Nguyen TAH Ngo KD Thieu HH Nguyen MT Nguyen DH et al Molecular screening of nasopharyngeal carcinoma: Detection of LMP-1, LMP-2 gene expression in Vietnamese nasopharyngeal swab samples Asian Pac J Cancer Prev 2019 20 9 2757276110.31557/APJCP.2019.20.9.2757697683031554374Search in Google Scholar

9Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995; 333(11): 693-698.Pathmanathan R Prasad U Sadler R Flynn K Raab-Traub N Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma N Engl J Med 1995 333 11 693 69810.1056/NEJM1995091433311037637746Search in Google Scholar

10Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002; 12(6): 431-441.Raab-Traub N Epstein-Barr virus in the pathogenesis of NPC Semin Cancer Biol 2002 12 6 431 44110.1016/S1044579X0200086XSearch in Google Scholar

11Zhao Y, Wang Y, Zeng S, Hu X. LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis. J Clin Pathol. 2012; 65(1): 41-45.Zhao Y Wang Y Zeng S Hu X LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis J Clin Pathol 2012 65 1 41 4510.1136/jclinpath-2011-20019822039283Search in Google Scholar

12Goodwin M, Yap AS. Classical cadherin adhesion molecules: Coordinating cell adhesion, signaling and the cytoskeleton. J Mol Histol. 2004; 35(9): 839-844.Goodwin M Yap AS Classical cadherin adhesion molecules: Coordinating cell adhesion, signaling and the cytoskeleton J Mol Histol 2004 35 9 839 84410.1007/s10735-004-1833-2Search in Google Scholar

13Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: How does cadherin dysfunction promote tumor progression? Oncogene. 2008; 27(55): 6920-6929.Jeanes A Gottardi CJ Yap AS Cadherins and cancer: How does cadherin dysfunction promote tumor progression? Oncogene 2008 27 55 6920 692910.1038/onc.2008.343Search in Google Scholar

14Tsao SW, Liu Y, Wang XX, Yuen PW, Leung SY, Yuen ST, et al. The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. Eur J Cancer. 2003; 39(4): 524-531.Tsao SW Liu Y Wang XX Yuen PW Leung SY Yuen ST et al The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells Eur J Cancer 2003 39 4 524 53110.1016/S0959-8049(02)00494-XSearch in Google Scholar

15Niemhom S, Kitazawa S, Kitazawa R, Maeda S, Leopairat J. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma. Cancer Detect Prev. 2008; 32(2): 127-134.Niemhom S Kitazawa S Kitazawa R Maeda S Leopairat J Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma Cancer Detect Prev 2008 32 2 127 13410.1016/j.cdp.2008.05.005Search in Google Scholar

16Ayadi W, Karray-Hakim H, Khabir A, Feki L, Charfi S, Boudawara T, et al. Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients. Anticancer Res. 2008; 28(4B): 2161-2167.Ayadi W Karray-Hakim H Khabir A Feki L Charfi S Boudawara T et al Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients Anticancer Res 2008 28 4B 2161 2167Search in Google Scholar

17Ran Y, Wu S, You Y. Demethylation of E-cadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy. J Biochem. 2011; 149(1): 49-54.Ran Y Wu S You Y Demethylation of E-cadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy J Biochem 2011 149 1 49 5410.1093/jb/mvq128Search in Google Scholar

18Ryan JL, Fan H, Glazer SL, Schichman SA, Raab-Traub N, Gulley ML. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segment: A novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn. 2004; 6(4): 378-385.Ryan JL Fan H Glazer SL Schichman SA Raab-Traub N Gulley ML Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segment: A novel approach to screen for the virus in paraffin-embedded tissue and plasma J Mol Diagn 2004 6 4 378 38510.1016/S1525-1578(10)60535-1Search in Google Scholar

19Al-Mozaini M, Bodelon G, Karsstegl CE, Jin B, Al-Ahdal M, Farrell PJ. Epstein-Barr virus BART gene expression. J Gen Virol. 2009; 90(Pt 2): 307-316.Al-Mozaini M Bodelon G Karsstegl CE Jin B Al-Ahdal M Farrell PJ Epstein-Barr virus BART gene expression J Gen Virol 2009 90 Pt 2 307 31610.1099/vir.0.006551-019141439Search in Google Scholar

20Banko A, Lazarevic I, Cupic M, Stevanovic G, Boricic I, Jovanovic T. Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients. J Med Virol. 2012; 84(4): 632-642.Banko A Lazarevic I Cupic M Stevanovic G Boricic I Jovanovic T Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients J Med Virol 2012 84 4 632 64210.1002/jmv.2321722337303Search in Google Scholar

21Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol. 2012; 22(2): 144-153.Dawson CW Port RJ Young LS The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC) Semin Cancer Biol 2012 22 2 144 15310.1016/j.semcancer.2012.01.00422249143Search in Google Scholar

22Hao SP, Tsang NM, Chang KP, Ueng SH. Molecular diagnosis of nasopharyngeal carcinoma: Detecting LMP-1 and EBNA by nasopharyngeal swab. Otolaryngol Head Neck Surg. 2004; 131(5): 651-654.Hao SP Tsang NM Chang KP Ueng SH Molecular diagnosis of nasopharyngeal carcinoma: Detecting LMP-1 and EBNA by nasopharyngeal swab Otolaryngol Head Neck Surg 2004 131 5 651 65410.1016/j.otohns.2004.04.01315523443Search in Google Scholar

23See HS, Yap YY, Yip WK, Seow HF. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J Surg Oncol. 2008; 6: 18-27.See HS Yap YY Yip WK Seow HF Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia World J Surg Oncol 2008 6 18 2710.1186/1477-7819-6-18226571618275617Search in Google Scholar

24Kang MS, Kieff E. Epstein-Barr virus latent genes. Exp Mol Med. 2015; 47(1): e131-e146.Kang MS Kieff E Epstein-Barr virus latent genes Exp Mol Med 2015 47 1 e131 e14610.1038/emm.2014.84431458325613728Search in Google Scholar

25Li Z, Lin SX, Liang YJ. Influence of E-cadherin promoter methylation and mutation of beta-catenin on invasion and metastasis of nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi. 2003; 25(3): 238-242.Li Z Lin SX Liang YJ Influence of E-cadherin promoter methylation and mutation of beta-catenin on invasion and metastasis of nasopharyngeal carcinoma cells Zhonghua Zhong Liu Za Zhi 2003 25 3 238 242Search in Google Scholar

26Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000; 60(21): 5954-5958.Palmisano WA Divine KK Saccomanno G Gilliland FD Baylin SB Herman JG et al Predicting lung cancer by detecting aberrant promoter methylation in sputum Cancer Res 2000 60 21 5954 5958Search in Google Scholar

27Lin SX, Zong YS, Chu B, Zhong BL, Li Z, Liang YJ, et al. Relationship between the expressions of LMP-1 and e-cadherin/beta-catenin in nasopharyngeal carcinoma. Chin J Cancer Res. 2002; 14(3): 202-205.Lin SX Zong YS Chu B Zhong BL Li Z Liang YJ et al Relationship between the expressions of LMP-1 and e-cadherin/beta-catenin in nasopharyngeal carcinoma Chin J Cancer Res 2002 14 3 202 20510.1007/s11670-002-0045-0Search in Google Scholar

28Qiu X, Qiao F, Su X, Zhao Z, Fan H. Epigenetic activation of E-cadherin is a candidate therapeutic target in human hepatocellular carcinoma. Exp Ther Med. 2010; 1(3): 519-523.Qiu X Qiao F Su X Zhao Z Fan H Epigenetic activation of E-cadherin is a candidate therapeutic target in human hepatocellular carcinoma Exp Ther Med 2010 1 3 519 52310.3892/etm_00000082344593322993570Search in Google Scholar

29Corso G, Bonanni B, Veronesi P. Tumor inactivation of E-cadherin: A new tool for breast cancer treatment? Ann Transl Med. 2018; 6(Suppl 1): S6.Corso G Bonanni B Veronesi P Tumor inactivation of E-cadherin: A new tool for breast cancer treatment? Ann Transl Med 2018 6 Suppl 1 S610.21037/atm.2018.08.45629160130613582Search in Google Scholar

30Christman JK. 5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy. Oncogene. 2002; 21(35): 5483-5495.Christman JK 5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy Oncogene 2002 21 35 5483 549510.1038/sj.onc.120569912154409Search in Google Scholar

31Nam JS, Ino Y, Kanai Y, Sakamoto M, Hirohashi S. 5-Aza-2’-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis. Clin Exp Metastasis. 2004; 21(1): 49-56.Nam JS Ino Y Kanai Y Sakamoto M Hirohashi S 5-Aza-2’-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis Clin Exp Metastasis 2004 21 1 49 5610.1023/B:CLIN.0000017180.19881.c1Search in Google Scholar

32Hannigan A, Wilson JB. Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition. Mol Cancer. 2010; 9: 184.Hannigan A Wilson JB Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition Mol Cancer 2010 9 18410.1186/1476-4598-9-184291398420618963Search in Google Scholar